82743

PrECOG 0105: Final Efficacy Results From a Phase II Study of Gemcitabine & Carboplatin Plus Iniparib (BSI-201) As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer